Ovarian Sertoli-Leydig cell tumor
Citation, DOI, disclosures and article data
At the time the article was created Yuranga Weerakkody had no recorded disclosures.View Yuranga Weerakkody's current disclosures
At the time the article was last revised Jeremy Jones had no recorded disclosures.View Jeremy Jones's current disclosures
Ovarian Sertoli-Leydig cell tumors (SLCT), also known as ovarian androblastomas, are a subtype of ovarian sex cord-stromal tumor.
They are rare and only account for ~0.5% of all ovarian tumors. While they can present at any age, they typically present <30 years old, with a mean age of 14 years.
In ~30-50% of patients, the presenting symptoms are related to clinical signs of androgenic activity 6. Many patients have symptoms of virilization depending on the quantity of androgen production. A small subset is hyperoestrogenic.
Hormonally inactive tumors often have a nonspecific presentation such as an abdominal mass and/or pain. The majority of patients present with stage I disease.
Most tumors are unilateral (>90% of cases) and confined to the ovaries. These tumors are characterized by the presence of testicular structures that produce androgens. However, only 30% are hormonally active.
Ovarian SLCTs can be divided into four subtypes:
The tumors may contain heterologous elements in approximately 20% of cases. These can, in turn, be further separated into two basic types: endodermal and mesenchymal. Heterologous hepatic differentiation is responsible for elevated AFP levels 11.
SLCTs are usually unilateral.
Imaging features are nonspecific and variable. SLCT may manifest as a well-defined, enhancing solid mass 3 or as a cystic lesion 6. It typically presents as a solid mass with intratumoral cysts.
The signal intensity on T2-weighted MR images depends on their fibrous content. Most tumors demonstrate predominantly low T2 signal intensity with scattered areas of high signal intensity 5.
Treatment and prognosis
Most tumors are benign although ~10-20% can be malignant.
- 1. Tandon R, Goel P, Saha P, Takkar N, Punia R. A Rare Ovarian Tumor - Sertoli-Leydig Cell Tumor with Heterologous Element. MedGenMed. 2007;9(4):44. PMC2234306 [Pubmed]
- 2. Caringella A, Loizzi V, Resta L, Ferreri R, Loverro G. A Case of Sertoli-Leydig Cell Tumor in a Postmenopausal Woman. Int J Gynecol Cancer. 2006;16(1):435-8. doi:10.1111/j.1525-1438.2006.00203.x [Pubmed]
- 3. Jung S, Lee J, Rha S, Byun J, Jung J, Hahn S. CT and MR Imaging of Ovarian Tumors with Emphasis on Differential Diagnosis. Radiographics. 2002;22(6):1305-25. doi:10.1148/rg.226025033 [Pubmed]
- 4. Tanaka Y, Tsunoda H, Kitagawa Y, Ueno T, Yoshikawa H, Saida Y. Functioning Ovarian Tumors: Direct and Indirect Findings at MR Imaging. Radiographics. 2004;24 Suppl 1(suppl_1):S147-66. doi:10.1148/rg.24si045501 [Pubmed]
- 5. Shanbhogue A, Shanbhogue D, Prasad S, Surabhi V, Fasih N, Menias C. Clinical Syndromes Associated with Ovarian Neoplasms: A Comprehensive Review. Radiographics. 2010;30(4):903-19. doi:10.1148/rg.304095745 [Pubmed]
- 6. Jung S, Rha S, Lee J et al. CT and MRI Findings of Sex Cord-Stromal Tumor of the Ovary. AJR Am J Roentgenol. 2005;185(1):207-15. doi:10.2214/ajr.185.1.01850207 [Pubmed]
- 7. Roth L, Anderson M, Govan A, Langley F, Gowing N, Woodcock A. Sertoli-Leydig Cell Tumors: A Clinicopathologic Study of 34 Cases. Cancer. 1981;48(1):187-97. doi:10.1002/1097-0142(19810701)48:1<187::aid-cncr2820480130>3.0.co;2-1 [Pubmed]
- 8. Wolfgang Dähnert. Radiology Review Manual. (2011) ISBN: 9781609139438
- 9. Young R & Scully R. Ovarian Sertoli-Leydig Cell Tumors. A Clinicopathological Analysis of 207 Cases. Am J Surg Pathol. 1985;9(8):543-69. doi:10.1097/00000478-198508000-00001 [Pubmed]
- 10. Zizi-Sermpetzoglou A, Petrakopoulou N, Tepelenis N, Savvaidou V, Manoloudaki K, Katsoulis M. Pure Sertoli Cell Tumor. A Case Report and Review of the Literature. Eur J Gynaecol Oncol. 2010;31(1):117-9. [Pubmed]
- 11. Heo S, Kim J, Shin S et al. Review of Ovarian Tumors in Children and Adolescents: Radiologic-Pathologic Correlation. Radiographics. 2014;34(7):2039-55. doi:10.1148/rg.347130144 [Pubmed]